FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: video sharing website

Sort
E.g., 2013-05-24
E.g., 2013-05-24
Enter a comma separated list of user names.

Apricus Biosciences Incorporated (Nasdaq:APRI) According to a a definitive agreement between the companies, Apricus Biosciences Incorporated will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy?the leakage of chemotherapy drugs from veins into surrounding tissues.

Apricus Biosciences Incorporated (Nasdaq:APRI) According to a a definitive agreement between the companies, Apricus Biosciences Incorporated will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy?the leakage of chemotherapy drugs from veins into surrounding tissues.

Apricus Biosciences Incorporated (Nasdaq:APRI) According to a a definitive agreement between the companies, Apricus Biosciences Incorporated will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy?the leakage of chemotherapy drugs from veins into surrounding tissues.

Apricus Biosciences Incorporated (Nasdaq:APRI) According to a a definitive agreement between the companies, Apricus Biosciences Incorporated will acquire Topotarget USA, who owns Totect (Dexrazoxane HCl), the only drug approved by the FDA to treat a potentially serious complication of cancer therapy?the leakage of chemotherapy drugs from veins into surrounding tissues.

ADVERTISE WITH US